ProCE Banner Activity

COVID-19 in Patients With Immunocompromise: An Ounce of Prevention Is Worth a Pound of Cure

Clinical Thought
Patients with immunocompromise are at risk for poor outcomes if infected with COVID-19. Read my take on why COVID-19 prevention in this population is so important.

Released: November 17, 2022

Expiration: November 16, 2023

No longer available for credit.

Share

Faculty

Alicia Lichvar

Alicia Lichvar, PharmD, MS, BCPS, BCTXP

Affiliate Faculty
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of California, San Diego
Clinical Transplant Pharmacist
Center for Transplantation
University of San Diego Health
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by an educational grant from

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Alicia Lichvar, PharmD, MS, BCPS, BCTXP

Affiliate Faculty
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of California, San Diego
Clinical Transplant Pharmacist
Center for Transplantation
University of San Diego Health
La Jolla, California

Alicia Lichvar, PharmD, MS, BCPS, BCTXP: consultant/advisor/speaker: Wolters Kluwer.